People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioLineRx Ltd. | — | Pharmaceuticals | Series A | $13.4M | $136.1M | 2020 |
Michael J. Anghel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael J. Anghel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Barbara Jean Bormann | 1 | 1 |
| Mali A. Zeevi | 1 | 1 |
| Raphael Jean Hofstein | 1 | 1 |
| Avraham Jean Molcho | 1 | 1 |
| Philip A. Serlin | 1 | 1 |
| Aharon Schwartz | 1 | 1 |
| Nurit J. Benjamini | 1 | 1 |
| Abi A. Vainstein-Haras | 1 | 1 |
| Sandra Jean Panem | 1 | 1 |
| Ella A. Sorani | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.